EFFECT OF LOW-DOSE BOLUS, LOW-DOSE CONTINUOUS INFUSION, AND HIGH-DOSE CONTINUOUS INFUSION INTERLEUKIN-2 ON INVIVO AND INVITRO GENERATION OF LYMPHOKINE ACTIVATED KILLER CELL-ACTIVITY

被引：0
|
作者：
BOLTON, JS
CHOI, YS
COOPER, ES
FLAUM, MA
LEAVITT, D
机构：
[1] ALTON OCHSNER MED FDN & OCHSNER CLIN,DEPT SURG,NEW ORLEANS,LA 70121
[2] HOFFMANN LA ROCHE INC,NUTLEY,NJ 07110
来源：
CLINICAL RESEARCH | 1989年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A23 / A23
页数：1
相关论文
共 50 条
  • [1] PHARMACOLOGICAL STUDIES OF LOW-DOSE AND HIGH-DOSE CONTINUOUS INFUSION CYTOSINE-ARABINOSIDE
    KUFE, DW
    SPRIGGS, DR
    GRIFFIN, JD
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 149 - 158
  • [2] MAXIMUM TOLERATED DOSE FOR LOW-DOSE CONTINUOUS INFUSION CISPLATIN
    HAZUKA, MB
    BUNN, PA
    CROWLEY, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (03): : 869 - 870
  • [3] MAXIMUM TOLERATED DOSE FOR LOW-DOSE CONTINUOUS INFUSION CISPLATIN
    ELLERBROEK, N
    KOMAKI, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 22 (05): : 1164 - 1164
  • [4] GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY BY LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND TUMOR-CELLS
    YAMAMOTO, S
    HOON, DSB
    CHANDLER, P
    SCHMID, I
    IRIE, RF
    CELLULAR IMMUNOLOGY, 1990, 128 (02) : 516 - 527
  • [5] CONTINUOUS INFUSION OF LOW-DOSE INSULIN IN DIABETIC KETOACIDOSIS
    不详
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 1979, 78 (08): : 540 - 540
  • [6] DIABETIC KETOACIDOSIS CONTINUOUS INFUSION OF LOW-DOSE INSULIN
    NUSSBAUM, M
    ABRAMS, C
    SHENKER, IR
    NEW YORK STATE JOURNAL OF MEDICINE, 1978, 78 (09) : 1423 - 1424
  • [7] INVIVO ADMINISTRATION OF LOW-DOSE HUMAN INTERLEUKIN-2 INDUCES LYMPHOKINE-ACTIVATED KILLER-CELLS FOR ENHANCED CYTOLYSIS INVITRO
    HANCOCK, GE
    MOLLOY, A
    AB, BK
    KIESSLING, R
    BECXBLEUMINK, M
    COHN, ZA
    KAPLAN, G
    CELLULAR IMMUNOLOGY, 1991, 132 (02) : 277 - 284
  • [8] Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2
    Soiffer, RJ
    Murray, C
    Shapiro, C
    Collins, H
    Chartier, S
    Lazo, S
    Ritz, J
    CLINICAL CANCER RESEARCH, 1996, 2 (03) : 493 - 499
  • [9] A RANDOMIZED TRIAL OF HIGH-DOSE BOLUS METOCLOPRAMIDE VERSUS LOW-DOSE CONTINUOUS INFUSION METOCLOPRAMIDE IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
    DANA, BW
    MCDERMOTT, M
    EVERTS, E
    ABDULHAY, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03): : 253 - 256
  • [10] Rebound hypotension following terlipressin bolus infusion can be prevented by continuous low-dose infusion of terlipressin
    M Lange
    K Bröking
    C Ertmer
    D Traber
    C Hucklenbruch
    H Van Aken
    M Westphal
    Critical Care, 11 (Suppl 2):
12345